Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives

被引:35
作者
Moribe, Kunikazu [1 ]
Limwikrant, Waree [1 ]
Higashi, Kenjirou [1 ]
Yamamoto, Keiji [1 ]
机构
[1] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1,Inohana, Chiba 2608675, Japan
关键词
D O I
10.1155/2011/138929
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug nanoparticle formulation using ascorbic acid derivatives and its therapeutic uses have recently been introduced. Hydrophilic ascorbic acid derivatives such as ascorbyl glycoside have been used not only as antioxidants but also as food and pharmaceutical excipients. In addition to drug solubilization, drug nanoparticle formation was observed using ascorbyl glycoside. Hydrophobic ascorbic acid derivatives such as ascorbylmono- and di-n-alkyl fatty acid derivatives are used either as drugs or carrier components. Ascorbyl n-alkyl fatty acid derivatives have been formulated as antioxidants or anticancer drugs for nanoparticle formulations such as micelles, microemulsions, and liposomes. ASC-P vesicles called aspasomes are submicron-sized particles that can encapsulate hydrophilic drugs. Several transdermal and injectable formulations of ascorbyl n-alkyl fatty acid derivatives were used, including ascorbyl palmitate.
引用
收藏
页数:9
相关论文
共 33 条
  • [1] Surface modification of pharmaceutical nanocarriers with ascorbate residues improves their tumor-cell association and killing and the cytotoxic action of encapsulated paclitaxel in vitro
    D'Souza, Gerard G. M.
    Wang, Tao
    Rockwell, Karen
    Torchilin, Vladimir P.
    [J]. PHARMACEUTICAL RESEARCH, 2008, 25 (11) : 2567 - 2572
  • [2] Investigation of liposomes as carriers of sodium ascorbyl phosphate for cutaneous photoprotection
    Foca, A
    Gasperlin, M
    Kristl, J
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 291 (1-2) : 21 - 29
  • [3] Targeted Antitumoral Dehydrocrotonin Nanoparticles With L-Ascorbic Acid 6-Stearate
    Frungillo, Lucas
    Martins, Dorival
    Teixeira, Sergio
    Anazetti, Maristela Conti
    Melo, Patricia Da Silva
    Duran, Nelson
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 98 (12) : 4796 - 4807
  • [4] Ascorbyl palmitate vesicles (Aspasomes): formation, characterization and applications
    Gopinath, D
    Ravi, D
    Rao, BR
    Apte, SS
    Renuka, D
    Rambhau, D
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 271 (1-2) : 95 - 113
  • [5] Application of ascorbic acid 2-glucoside as a solubilizing agent for clarithromycin: Solubilization and nanoparticle formation
    Inoue, Yutaka
    Yoshimura, Sachie
    Tozuka, Yuichi
    Moribe, Kunikazu
    Kumamoto, Takuya
    Ishikawa, Tsutomu
    Yamamoto, Keiji
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 331 (01) : 38 - 45
  • [6] Improvement of physicochemical properties of N-4472. Part III. VC/N-4472 complex formation and self-association in aqueous solution
    Itoh, K
    Tozuka, Y
    Oguchi, T
    Yamamoto, K
    [J]. CHEMICAL & PHARMACEUTICAL BULLETIN, 2003, 51 (01) : 40 - 45
  • [7] Biocatalytic synthesis of ascorbyl esters and their biotechnological applications
    Karmee, Sanjib Kumar
    [J]. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2009, 81 (06) : 1013 - 1022
  • [8] Effect of colloidal carriers on ascorbyl palmitate stability
    Kristl, J
    Volk, B
    Gasperlin, M
    Sentjurc, M
    Jurkovic, P
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 19 (04) : 181 - 189
  • [9] Skin permeation enhancement of ascorbyl palmitate by liposomal hydrogel (lipogel) formulation and electrical assistance
    Lee, Sangkil
    Lee, Jaehwi
    Choi, Young Wook
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (02) : 393 - 396
  • [10] DETERMINATION OF ASCORBYL DIPALMITATE IN COSMETIC WHITENING POWDERS BY LIQUID-CHROMATOGRAPHY
    LIEN, MH
    HUANG, BC
    HSU, MC
    [J]. JOURNAL OF CHROMATOGRAPHY, 1993, 645 (02): : 362 - 365